Kanamycin (sulfate)

ArtNr	HY-16566A-5g
Hersteller	MedChem Express
CAS-Nr.	25389-94-0
Menge	5 g
Quantity options	10 mM/1 mL 1 g 200 mg 5 g
Kategorie	Food Safety Antibiotics Inhibitors & Compound Libraries Small Molecules
Typ	Inhibitors
Specific against	other
Purity	99.96
Citations	[1]YANAGISAWA K, et al. Studies on kanamycin, a new antibiotic against tubercle bacilli. I. Effect on virulent tubercle bacilli in vitro and in mice. J Antibiot (Tokyo). 1957 Nov;10(6):233-5. \|[2]Nishi T, et al. Experimental respiratory tract infection with Klebsiella pneumoniae DT-S in mice: chemotherapy with kanamycin. Antimicrob Agents Chemother. 1980 Mar;17(3):494-505. \|[3]Misumi M, et al. Interaction of kanamycin and related antibiotics with the large subunit of ribosomes and the inhibition of translocation. Biochem Biophys Res Commun. 1978 Sep 29;84(2):358-65.\|[4]Misumi M, et al. Mechanism of inhibition of translocation by kanamycin and viomycin: a comparative study with fusidic acid. Biochem Biophys Res Commun. 1980 Jan 29;92(2):647-54. ACS Chem Biol. 2021 Dec 15.\|ACS Infect Dis. 2024 Apr 12;10(4):1327-1338.\|Cell Death Dis. 2021 May 18;12(6):509.\|Int J Hydrogen Energy. 2018, 43(30), 13821-13828.\|Microb Biotechnol. 2021 Mar 15.\|Nucleic Acids Res. 2022 Dec 12;gkac1141.\|Sci Adv. 2023 Feb 17;9(7):eade4770.\|Adv Sci (Weinh). 2024 Jun 21.\|AMB Express. 2024 Dec 24;14(1):141.\|Aquat Toxicol. 2025 Feb 9:280:107284.\|bioRxiv. 2025 January 19.\|Food Chem. 2022 Sep 26;403:134399.\|Int J Med Microbiol. 2023 Mar 28;313(2):151578.\|J Periodontol. 2024 Jul 4.\|Vet Res Commun. 2024 Sep 26.
Smiles	OS(O)(=O)=O.O[C@H]1[C@](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)([H])O[C@H](CN)[C@@H](O)[C@@H]1O
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	Kanamycin A (sulfate)
Versandbedingung	Raumtemperatur
Lieferbar
Manufacturer - Type	Natural Products
Manufacturer - Applications	COVID-19-immunoregulation
Manufacturer - Targets	Antibiotic; Bacterial
Shipping Temperature	Room Temperature
Storage Conditions	4°C (Powder, sealed storage, away from moisture)
Molecular Weight	582.58
Product Description	Kanamycin (Kanamycin A) sulfate is an orally active antibacterial (gram-negative/positive bacteria) agent, inhibits translocation and causes misencoding by binding to the 70 S ribosomal subunit. Kanamycin sulfate shows good inhibitory activity to both M. tuberculosis (sensitive and drug-resistant ) and K. pneumonia, which can be used in studies of tuberculosis and pneumonia[1][2][3][4].
Manufacturer - Research Area	Infection
Solubility	DMSO: < 1 mg/mL\|H2O: ≥ 25 mg/mL
Manufacturer - Pathway	Anti-infection
Clinical information	Launched

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Arbeitsanleitung (Data Sheet) anfordern

Produkt-Datenblatt anfordern

HY-16566A-5g-safety-datasheet.pdf